Trails Edge Capital Partners, LP / CYTK
Trails Edge Capital Partners, LP’s Cytokinetics Inc Position
Does Trails Edge Capital Partners, LP own Cytokinetics Inc (CYTK)? Yes — 300.0K shares worth $20M (+4.53% of its 13F portfolio) as of Q1 2026.
Position Value
$20M
Q1 2026
Shares
300.0K
% of Portfolio
+4.53%
Quarters Held
1
currently held
Position History CYTK
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 300.0K | $20M | +4.53% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Trails Edge Capital Partners, LP’s full portfolio or all institutional holders of CYTK.